BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?
No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!
 |
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | |
United Kingdom Statutory Instruments |
||
|
You are here: BAILII >> Databases >> United Kingdom Statutory Instruments >> The Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2021 No. 1427 URL: http://www.bailii.org/uk/legis/num_reg/2021/uksi_20211427_en_1.html |
||
[New search] [Help]
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
Statutory Instruments
Dangerous Drugs
Made
10th December 2021
Laid before Parliament
15th December 2021
Coming into force
15th June 2022
The Secretary of State makes the following Regulations in exercise of the powers conferred by sections 7(1)(a) and (b), 10(1), 22(1)(a) and 31(1)(a) of the Misuse of Drugs Act 1971( 1).
In accordance with section 31(3) of that Act the Secretary of State has consulted the Advisory Council on the Misuse of Drugs.
1.—(1) These Regulations may be cited as the Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2021 and come into force on 15th June 2022.
(2) These Regulations extend to England and Wales and Scotland.
2.—(1) The following amendments are made to the Misuse of Drugs Regulations 2001( 2).
(2) Omit regulation 4B (Exceptions for gamma–butyrolactone and 1,4–butanediol)( 3).
(3) In paragraph 1(a) of Schedule 1( 4)—
(a) after “Bufotenine” insert “1,4-Butanediol”;
(b) after “Fungus (of any kind) which contains psilocin or an ester of psilocin” insert “Gamma-butyrolactone”.
Kit Malthouse
Minister of State
Home Office
10th December 2021
(This note is not part of the Regulations)
These Regulations amend the Misuse of Drugs Regulations 2001 ( S.I. 2001/3998) (“ the 2001 Regulations”).
Regulation 2(2) removes regulation 4B of the 2001 Regulations, that made it lawful to import, export, produce, supply, offer to supply or possess Gamma–butyrolactone (GBL) and 1,4–Butanediol (1,4-BD) in certain circumstances.
Regulation 2(3) adds 1,4-Butanediol (1,4-BD) and Gamma-butyrolactone (GBL) to Schedule 1 to the 2001 Regulations. The Schedule in which a controlled drug is placed affects the extent to which the drug can be lawfully imported, exported, produced, supplied or possessed. The controlled drugs placed in Schedule 1 to the 2001 Regulations are those subject to the tightest controls, requiring a Home Office licence in order to access such drugs.
A full impact assessment of the effect that this instrument will have on the costs of business, the voluntary sector and the public sector is submitted alongside the Explanatory Memorandum which is available alongside the instrument atwww.legislation.gov.uk. Copies may be obtained from the Home Office at 2 Marsham Street, London, SW1P 4DF.
1971 c. 38. Section 22 was amended by the Police Reform and Social Responsibility Act 2011 (c. 13), Schedule 17, paragraph 14. See the definition of “prescribed” in section 37(1).
Relevant amending instruments are S.I. 2009/3136, 2011/448.
Relevant amending instrument is S.I. 2005/1653.
